Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

327 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Non-eosinophilic corticosteroid unresponsive asthma.
Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Pavord ID, et al. Lancet. 1999 Jun 26;353(9171):2213-4. doi: 10.1016/S0140-6736(99)01813-9. Lancet. 1999. PMID: 10392993 No abstract available.
Inflammometry to assess airway diseases.
Pavord ID, Shaw DE, Gibson PG, Taylor DR. Pavord ID, et al. Lancet. 2008 Sep 20;372(9643):1017-9. doi: 10.1016/S0140-6736(08)61421-X. Lancet. 2008. PMID: 18805315 No abstract available.
Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
Gonem S, Berair R, Singapuri A, Hartley R, Laurencin MFM, Bacher G, Holzhauer B, Bourne M, Mistry V, Pavord ID, Mansur AH, Wardlaw AJ, Siddiqui SH, Kay RA, Brightling CE. Gonem S, et al. Among authors: pavord id. Lancet Respir Med. 2016 Sep;4(9):699-707. doi: 10.1016/S2213-2600(16)30179-5. Epub 2016 Aug 5. Lancet Respir Med. 2016. PMID: 27503237 Clinical Trial.
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Pavord ID, et al. Lancet. 2012 Aug 18;380(9842):651-9. doi: 10.1016/S0140-6736(12)60988-X. Lancet. 2012. PMID: 22901886 Clinical Trial.
Mepolizumab and exacerbations of refractory eosinophilic asthma.
Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Haldar P, et al. Among authors: pavord id. N Engl J Med. 2009 Mar 5;360(10):973-84. doi: 10.1056/NEJMoa0808991. N Engl J Med. 2009. PMID: 19264686 Free PMC article. Clinical Trial.
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Green RH, et al. Among authors: pavord id. Lancet. 2002 Nov 30;360(9347):1715-21. doi: 10.1016/S0140-6736(02)11679-5. Lancet. 2002. PMID: 12480423 Clinical Trial.
After asthma: redefining airways diseases.
Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A. Pavord ID, et al. Lancet. 2018 Jan 27;391(10118):350-400. doi: 10.1016/S0140-6736(17)30879-6. Epub 2017 Sep 11. Lancet. 2018. PMID: 28911920 Review. No abstract available.
The asthmas in 2015 and beyond: a Lancet Commission.
Bush A, Kleinert S, Pavord ID. Bush A, et al. Among authors: pavord id. Lancet. 2015 Apr 4;385(9975):1273-5. doi: 10.1016/S0140-6736(15)60654-7. Lancet. 2015. PMID: 25890896 No abstract available.
Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample.
Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S. Britton J, et al. Among authors: pavord i. Lancet. 1994 Aug 6;344(8919):357-62. doi: 10.1016/s0140-6736(94)91399-4. Lancet. 1994. PMID: 7914305
Azithromycin in uncontrolled asthma.
Brusselle G, Pavord I. Brusselle G, et al. Among authors: pavord i. Lancet. 2017 Aug 12;390(10095):629-630. doi: 10.1016/S0140-6736(17)31547-7. Epub 2017 Jul 4. Lancet. 2017. PMID: 28687412 No abstract available.
327 results
Jump to page